Development of Model on Mothers Self-Efficacy in Preventing Recurrence of Non-Pneumonia Acute Respiratory Infection among Toddlers
Abstract
Introduction: Acute Respiratory Infection (ARI) is the leading cause of morbidity and mortality in children. A cough and cold diseases such as rhinitis, pharyngitis, tonsillitis and other upper respiratory diseases are classified as non-pneumonia. ARIs that are not appropriately handled will affect the lung tissue and cause severity and even death. The purpose of this study is to develop a model of self-efficacy (SE) among mother to prevent recurrent (PR) non pneumonia (NP)-ARI on toddlers based on the integration of Precede-Proceed Model and Health Belief Model. Method: This study used cross-sectional design. The population were a mother with a toddler in Tanggalrejo Village of Mojoagung Jombang. A hundred toddler’s mothers were recruited as samples by cluster sampling. Variables in this study were predisposing-enabling-reinforcing factors, main constructs of perceived (MCP), perceived threat, SE and PRNP-ARI. Data were collected using questionnaire, and Focus Group Discussion then analyzed using Partial Least Square (PLS). Results: The SE improvement model for the PRNP-ARI was formed from predisposing-enabling-reinforcing factors, MCP, perceived threat, and maternal SE. The greatest effect was on MCP against a perceived threat with T statistic value = 11.07. Conclusion: Increasing SE of toddler's mother can be done by educating mother about ARI concept, conventional ARI treatment, environmental modification, benefits of mask use, clean and healthy life behavior, proper…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.